Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01E PROTEIN KINASE INHIBITORS
     L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
     L01X OTHER ANTINEOPLASTIC AGENTS
       L01XA Platinum compounds [DG:DG01679]
       L01XB Methylhydrazines
       L01XD Sensitizers used in photodynamic/radiation therapy
       L01XF Retinoids for cancer treatment
       L01XG Proteasome inhibitors [DG:DG03134]
         L01XG01 Bortezomib [DG:DG03219]
         L01XG02 Carfilzomib
           D08880  Carfilzomib (JAN/USAN/INN) <JP/US>
         L01XG03 Ixazomib [DG:DG01269]
       L01XH Histone deacetylase (HDAC) inhibitors [DG:DG03133]
       L01XJ Hedgehog pathway inhibitors [DG:DG01566]
       L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors [DG:DG02942]
       L01XL Antineoplastic cell and gene therapy
       L01XX Other antineoplastic agents
       L01XY Combinations of antineoplastic agents
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 22, 2024
According to WHO's ATC 2024

» Japanese version